The amyloid (Aβ) hypothesis of Alzheimer’s disease (AD) has primarily been driven by the observation that genetic variability that alters amyloid precursor protein (APP) metabolism increases de position of Aβ1. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.